StimGuard Clinical Trial

StimGuard yesterday announced plans for a clinical trial comparing its nerve stimulator with the InterStim sacral nerve stimulator made by Medtronic (NYSE:MDT).

Pompano Beach, Fla.-based StimGuard is already running a pivotal study of its technology, a miniature implantable device designed to treat urinary incontinence resulting from refractory overactive bladder syndrome. The device is implanted at the tibial nerve through a needle-sized introducer and uses wireless technology to stimulate the nerve.

The new study is designed to compare that treatment with InterStim sacral nerve stimulation therapy, which involves the surgical implantation of lead at the sacral nerve and a battery unit (StimGuard’s device uses an external transmitter).

StimGuard said it plans to commercialize the technology if the study proves successful.

Read the entire article: https://www.massdevice.com/stimguard-launches-head-head-trial-medtronics-interstim/